PRTA
PROTHENA CORP PUBLIC LTD CO
Company overview
- Market capitalization
- $447.66M
- Employees
- 67
- Latest publication
- 2026-09-29
About PROTHENA CORP PUBLIC LTD CO
Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation. Its product pipeline includes Prasinezumab, an investigational humanized monoclonal antibody which is in Phase 3 clinical trial for the treatment of parkinson's disease and other synucleinopathies. The company also develops Coramitug, an investigational antibody, which is in Phase 3 clinical trial for the treatment of transthyretin amyloidosis; BMS-986446, an anti-tau antibody which is in Phase 2 clinical trial to treat Alzheimer's disease; PRX019, an investigational antibody which is in Phase 1 clinical trial for the treatment of neurodegenerative diseases; and PRX123, a Dual Aß-Tau Vaccine, which is in preclinical trial for treating Alzheimer's disease. In addition, it develops discovery- and late-preclinical-stage programs include TDP-43 CYTOPE for the treatment of amyotrophic lateral sclerosis; PRX012, a next-generation anti-Aß antibody which is in phase 1 clinical trial to treat Alzheimer's disease; and PRX012-TfR, a preclinical program for the treatment of Alzheimer's disease. It has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target a-synuclein, including prasinezumab; and master collaboration agreement with Bristol Myers Squibb to develop and commercialize antibodies targeting tau, TDP-43. Prothena Corporation plc was incorporated in 2012 and is based in Dublin, Ireland.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,010,000USD | 51,084,000USD | 21,000USD | 4,420,000USD | 2,828,000USD | 2,123,000USD | 970,000USD | 132,014,000USD |
| Research Development | 8,798,000USD | 12,627,000USD | 14,586,000USD | 40,517,000USD | 50,811,000USD | 50,172,000USD | 50,723,000USD | 57,510,000USD |
| General And Administrative Expenses | 10,899,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 22,111,000USD | 24,375,000USD | 26,290,000USD | 89,036,000USD | 68,409,000USD | 67,020,000USD | 67,483,000USD | 73,637,000USD |
| Operating Income | -21,101,000USD | 25,791,000USD | -27,211,000USD | -84,616,000USD | -65,581,000USD | -64,897,000USD | -66,513,000USD | 58,377,000USD |
| Total Other Income Expense Net | 2,520,000USD | 6,931,000USD | 5,632,000USD | 3,651,000USD | 4,208,000USD | 5,396,000USD | 6,677,000USD | 6,470,000USD |
| Net Interest Income | 2,553,000USD | 2,416,000USD | 2,646,000USD | 3,794,000USD | 4,348,000USD | 5,387,000USD | 6,743,000USD | 6,521,000USD |
| Income Before Tax | -18,581,000USD | 32,722,000USD | -21,579,000USD | -80,965,000USD | -61,373,000USD | -59,501,000USD | -59,836,000USD | 64,847,000USD |
| Income Tax Expense | 2,000USD | 1,000USD | 10,000USD | 44,802,000USD | -1,178,000USD | -1,545,000USD | -835,000USD | -2,039,000USD |
| Net Income | -18,583,000USD | 32,721,000USD | -21,589,000USD | -125,767,000USD | -60,195,000USD | -57,956,000USD | -59,001,000USD | 66,886,000USD |
| Cost Of Revenue | — | 918,000USD | 942,000USD | — | — | 913,000USD | — | 57,510,000USD |
| Gross Profit | — | 50,166,000USD | -921,000USD | 4,420,000USD | 2,828,000USD | 2,123,000USD | 970,000USD | 132,014,000USD |
| Selling General Administrative | — | 12,666,000USD | 12,646,000USD | 15,910,000USD | 17,598,000USD | 16,848,000USD | 16,760,000USD | 16,127,000USD |
| Interest Income | — | 2,416,000USD | 2,646,000USD | 3,794,000USD | 4,348,000USD | 5,387,000USD | 6,743,000USD | 6,521,000USD |
| Tax Provision | — | 1,000USD | 10,000USD | 44,802,000USD | -1,178,000USD | -1,545,000USD | -835,000USD | -2,039,000USD |
| Net Income From Continuing Ops | — | 32,721,000USD | -21,589,000USD | -125,767,000USD | -60,195,000USD | -57,956,000USD | -59,001,000USD | 66,886,000USD |
| Ebit | — | 32,722,000USD | -21,579,000USD | -52,007,000USD | -61,373,000USD | -59,501,000USD | -59,836,000USD | 64,847,000USD |
| Ebitda | — | 33,640,000USD | -20,637,000USD | -51,782,000USD | -61,150,000USD | -59,280,000USD | -59,610,000USD | 65,078,000USD |
| Depreciation And Amortization | — | 918,000USD | 942,000USD | 225,000USD | 223,000USD | 221,000USD | 226,000USD | 231,000USD |
| Reconciled Depreciation | — | 184,000USD | 218,000USD | 225,000USD | 223,000USD | 221,000USD | 226,000USD | 231,000USD |
| Unclassified Operating Expenses | — | — | — | 32,609,000USD | — | — | — | — |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 893,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 135,157,000USD | 91,370,000USD | 53,905,000USD | 200,577,000USD | 853,000USD | 955,000USD | 27,519,000USD | 1,055,000USD |
| Cost Of Revenue | 3,585,000USD | 220,571,000USD | 6,741,000USD | 82,284,000USD | 74,884,000USD | 101,183,000USD | 134,547,000USD | 119,534,000USD |
| Gross Profit | 135,157,000USD | 91,370,000USD | 53,905,000USD | 200,577,000USD | 853,000USD | -100,228,000USD | 27,519,000USD | 1,055,000USD |
| Research Development | 222,519,000USD | 220,571,000USD | 135,562,000USD | 82,284,000USD | 74,884,000USD | 101,183,000USD | 134,547,000USD | 119,534,000USD |
| Selling General Administrative | 67,199,000USD | 61,835,000USD | 49,900,000USD | 46,318,000USD | 38,703,000USD | 42,482,000USD | 48,226,000USD | 41,056,000USD |
| Total Operating Expenses | 289,718,000USD | 282,406,000USD | 185,462,000USD | 128,602,000USD | 113,587,000USD | 143,665,000USD | 182,773,000USD | 160,590,000USD |
| Operating Income | -154,561,000USD | -191,036,000USD | -131,557,000USD | 71,975,000USD | -112,734,000USD | -158,855,000USD | -155,254,000USD | -159,535,000USD |
| Interest Income | 25,816,000USD | 31,014,000USD | 6,349,000USD | 42,000USD | 1,369,000USD | 6,389,000USD | 3,546,000USD | 556,000USD |
| Net Interest Income | 25,816,000USD | 31,014,000USD | 6,349,000USD | 42,000USD | 1,369,000USD | 2,692,000USD | -142,000USD | 556,000USD |
| Income Before Tax | -128,930,000USD | -160,480,000USD | -125,605,000USD | 71,921,000USD | -111,427,000USD | -156,115,000USD | -157,603,000USD | -158,964,000USD |
| Income Tax Expense | -6,620,000USD | -13,452,000USD | -8,656,000USD | 4,946,000USD | -283,000USD | -470,000USD | -4,366,000USD | 1,144,000USD |
| Tax Provision | -6,620,000USD | -13,452,000USD | -8,656,000USD | 4,946,000USD | -283,000USD | -470,000USD | -4,366,000USD | 1,144,000USD |
| Net Income | -122,310,000USD | -147,028,000USD | -116,949,000USD | 66,975,000USD | -111,144,000USD | -155,645,000USD | -153,237,000USD | -160,108,000USD |
| Net Income From Continuing Ops | -122,310,000USD | -147,028,000USD | -116,949,000USD | 66,975,000USD | -111,144,000USD | -155,645,000USD | -153,237,000USD | -160,108,000USD |
| Ebit | -128,930,000USD | -160,480,000USD | -131,557,000USD | 71,975,000USD | -112,734,000USD | -156,115,000USD | -155,254,000USD | -159,535,000USD |
| Ebitda | -128,037,000USD | -159,552,000USD | -130,813,000USD | 78,778,000USD | -105,757,000USD | -152,899,000USD | -152,187,000USD | -157,108,000USD |
| Depreciation And Amortization | 893,000USD | 928,000USD | 744,000USD | 6,803,000USD | 6,977,000USD | 3,216,000USD | 3,067,000USD | 2,427,000USD |
| Reconciled Depreciation | 893,000USD | 928,000USD | 744,000USD | 6,803,000USD | 6,977,000USD | 3,216,000USD | 3,067,000USD | — |
| Total Other Income Expense Net | 25,631,000USD | 30,556,000USD | 5,952,000USD | -54,000USD | 1,307,000USD | 2,740,000USD | -2,349,000USD | 571,000USD |
| Interest Expense | — | — | 6,696,000USD | 6,749,000USD | 8,284,000USD | 3,697,000USD | 3,688,000USD | 863,000USD |
| Net Income Applicable To Common Shares | — | — | -116,949,000USD | 66,975,000USD | -111,144,000USD | -155,645,000USD | -153,237,000USD | -160,108,000USD |
| Non Operating Income Net Other | — | — | — | -96,000USD | -62,000USD | 48,000USD | -2,207,000USD | 15,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 302,579,000USD | 349,894,000USD | 326,804,000USD | 352,628,000USD | 399,066,000USD | 495,336,000USD | 547,108,000USD | 595,254,000USD |
| Cash And Equivalents | 288,193,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 292,013,000USD | 339,201,000USD | 315,193,000USD | 339,974,000USD | 385,475,000USD | 436,173,000USD | 485,412,000USD | 534,984,000USD |
| Other Current Assets | 3,820,000USD | 9,739,000USD | 7,662,000USD | 9,131,000USD | 14,040,000USD | 18,238,000USD | 14,024,000USD | 15,722,000USD |
| Other Non Current Assets | 482,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 15,688,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 11,658,000USD | 32,517,000USD | 40,843,000USD | 51,436,000USD | 67,807,000USD | 48,459,000USD | 48,501,000USD | 46,422,000USD |
| Other Current Liabilities | 5,237,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 286,891,000USD | 312,616,000USD | 280,474,000USD | 294,989,000USD | 324,331,000USD | 437,680,000USD | 486,926,000USD | 534,362,000USD |
| Total Equity Including Noncontrolling Interest | 286,891,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 620,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 9,224,000USD | 9,351,000USD | 10,269,000USD | 11,312,000USD | 12,253,000USD | 12,898,000USD | 13,789,000USD | 14,654,000USD |
| Accounts Payable | 1,941,000USD | 4,299,000USD | 5,875,000USD | 10,503,000USD | 12,198,000USD | 16,027,000USD | 7,770,000USD | 10,330,000USD |
| Short Term Debt | 2,961,000USD | 2,893,000USD | 2,886,000USD | 2,879,000USD | 2,853,000USD | 2,628,000USD | 2,610,000USD | 2,613,000USD |
| Common Stock | 517,000USD | 530,000USD | 538,000USD | 538,000USD | 538,000USD | 538,000USD | 538,000USD | 538,000USD |
| Retained Earnings | -1,332,295,000USD | -1,313,712,000USD | -1,346,433,000USD | -1,324,844,000USD | -1,288,303,000USD | -1,162,536,000USD | -1,102,341,000USD | -1,044,385,000USD |
| Total Liab | — | 37,278,000USD | 46,330,000USD | 57,639,000USD | 74,735,000USD | 57,656,000USD | 60,182,000USD | 60,892,000USD |
| Other Current Liab | — | 23,695,000USD | 29,418,000USD | 35,369,000USD | 47,656,000USD | 21,906,000USD | 29,271,000USD | 24,647,000USD |
| Capital Stock | — | 530,000USD | 538,000USD | 538,000USD | 538,000USD | 538,000USD | 538,000USD | 538,000USD |
| Cash | — | 329,462,000USD | 307,531,000USD | 330,843,000USD | 371,435,000USD | 417,935,000USD | 471,388,000USD | 519,262,000USD |
| Cash And Short Term Investments | — | 329,462,000USD | 307,531,000USD | 330,843,000USD | 371,435,000USD | 417,935,000USD | 471,388,000USD | 519,262,000USD |
| Current Deferred Revenue | — | 1,630,000USD | 2,664,000USD | 2,685,000USD | 5,100,000USD | 7,898,000USD | 8,850,000USD | 8,832,000USD |
| Net Debt | — | -321,808,000USD | -293,671,000USD | -321,761,000USD | -361,654,000USD | -407,732,000USD | -460,545,000USD | -507,768,000USD |
| Short Long Term Debt Total | — | 7,654,000USD | 13,860,000USD | 9,082,000USD | 9,781,000USD | 10,203,000USD | 10,843,000USD | 11,494,000USD |
| Property Plant Equipment Gross | — | 16,587,000USD | 17,321,000USD | 18,224,000USD | 19,655,000USD | 21,297,000USD | 22,097,000USD | 22,741,000USD |
| Common Stock Shares Outstanding | — | 54,109,000shares | 53,831,000shares | 53,830,000shares | 53,827,000shares | 53,827,000shares | 53,815,000shares | 53,790,000shares |
| Non Current Assets Total | — | 10,693,000USD | 11,611,000USD | 12,654,000USD | 13,591,000USD | 59,163,000USD | 61,696,000USD | 60,270,000USD |
| Non Current Liabilities Total | — | 4,761,000USD | 5,487,000USD | 6,203,000USD | 6,928,000USD | 9,197,000USD | 11,681,000USD | 14,470,000USD |
| Non Currrent Assets Other | — | 482,000USD | 482,000USD | 482,000USD | 478,000USD | 1,354,000USD | 4,668,000USD | 4,614,000USD |
| Net Working Capital | — | 306,684,000USD | 274,350,000USD | 288,538,000USD | 317,668,000USD | 387,714,000USD | 436,911,000USD | 488,562,000USD |
| Unclassified Non Current Liabilities | — | 4,761,000USD | 5,487,000USD | 6,203,000USD | 6,928,000USD | 9,197,000USD | 11,681,000USD | 14,470,000USD |
| Unclassified Equity | — | 1,625,268,000USD | 1,625,831,000USD | 1,618,757,000USD | 1,611,558,000USD | 1,599,140,000USD | 1,588,191,000USD | 1,577,671,000USD |
| Unclassified Non Current Assets | — | — | — | — | — | 44,911,000USD | 43,239,000USD | 41,002,000USD |
| Net Receivables | — | — | — | — | — | — | 0USD | 0USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 326,804,000USD | 547,108,000USD | 696,382,000USD | 758,035,000USD | 609,366,000USD | 332,975,000USD | 419,268,000USD | 498,796,000USD |
| Other Current Assets | 7,662,000USD | 14,024,000USD | 15,293,000USD | 8,630,000USD | 5,702,000USD | 3,889,000USD | 2,584,000USD | 3,729,000USD |
| Total Liab | 46,330,000USD | 60,182,000USD | 135,017,000USD | 135,993,000USD | 143,324,000USD | 148,969,000USD | 146,347,000USD | 175,798,000USD |
| Total Stockholder Equity | 280,474,000USD | 486,926,000USD | 561,365,000USD | 622,042,000USD | 466,042,000USD | 184,006,000USD | 272,921,000USD | 322,998,000USD |
| Other Current Liab | 29,418,000USD | 29,271,000USD | 30,386,000USD | 22,962,000USD | 16,164,000USD | 16,183,000USD | 11,366,000USD | 11,757,000USD |
| Common Stock | 538,000USD | 538,000USD | 537,000USD | 521,000USD | 466,000USD | 399,000USD | 399,000USD | 399,000USD |
| Capital Stock | 538,000USD | 538,000USD | 537,000USD | 521,000USD | 466,000USD | 399,000USD | 399,000USD | 399,000USD |
| Retained Earnings | -1,346,433,000USD | -1,102,341,000USD | -980,031,000USD | -833,003,000USD | -716,054,000USD | -783,029,000USD | -671,885,000USD | -597,995,000USD |
| Cash | 307,531,000USD | 471,388,000USD | 618,830,000USD | 710,406,000USD | 579,094,000USD | 295,380,000USD | 375,723,000USD | 427,659,000USD |
| Cash And Short Term Investments | 307,531,000USD | 471,388,000USD | 618,830,000USD | 710,406,000USD | 579,094,000USD | 295,380,000USD | 375,723,000USD | 427,659,000USD |
| Total Current Assets | 315,193,000USD | 485,412,000USD | 639,282,000USD | 719,098,000USD | 584,809,000USD | 299,284,000USD | 378,375,000USD | 431,390,000USD |
| Total Current Liabilities | 40,843,000USD | 48,501,000USD | 56,891,000USD | 50,147,000USD | 33,452,000USD | 25,848,000USD | 17,714,000USD | 14,926,000USD |
| Current Deferred Revenue | 2,664,000USD | 8,850,000USD | 67,405,000USD | 11,442,000USD | 7,657,000USD | 4,927,000USD | 4,584,000USD | 110,242,000USD |
| Net Debt | -293,671,000USD | -460,545,000USD | -606,995,000USD | -703,933,000USD | -566,768,000USD | -277,542,000USD | -352,784,000USD | -376,113,000USD |
| Short Term Debt | 2,886,000USD | 2,610,000USD | 1,114,000USD | 6,473,000USD | 5,940,000USD | 5,512,000USD | 5,101,000USD | 1,645,000USD |
| Short Long Term Debt Total | 13,860,000USD | 10,843,000USD | 11,835,000USD | 6,473,000USD | 12,326,000USD | 17,838,000USD | 22,939,000USD | 51,546,000USD |
| Accounts Payable | 5,875,000USD | 7,770,000USD | 25,391,000USD | 9,270,000USD | 3,691,000USD | 4,117,000USD | 1,242,000USD | 1,470,000USD |
| Property Plant Equipment Net | 10,269,000USD | 13,789,000USD | 15,998,000USD | 8,008,000USD | 14,135,000USD | 20,362,000USD | 27,148,000USD | 52,835,000USD |
| Property Plant Equipment Gross | 17,321,000USD | 22,097,000USD | 23,413,000USD | 8,008,000USD | 14,135,000USD | 20,362,000USD | 27,148,000USD | 52,245,000USD |
| Common Stock Shares Outstanding | 53,829,000shares | 53,772,000shares | 53,216,000shares | 47,369,000shares | 48,464,000shares | 39,915,000shares | 39,882,000shares | 39,559,000shares |
| Non Current Assets Total | 11,611,000USD | 61,696,000USD | 57,100,000USD | 38,937,000USD | 24,557,000USD | 33,691,000USD | 40,893,000USD | 67,406,000USD |
| Non Current Liabilities Total | 5,487,000USD | 11,681,000USD | 78,126,000USD | 85,846,000USD | 109,872,000USD | 123,121,000USD | 128,633,000USD | 160,872,000USD |
| Non Currrent Assets Other | 482,000USD | 3,808,000USD | 7,209,000USD | 12,725,000USD | 3,351,000USD | 1,685,000USD | 3,789,000USD | 4,869,000USD |
| Net Working Capital | 274,350,000USD | 436,911,000USD | 582,391,000USD | 668,951,000USD | 551,357,000USD | 273,436,000USD | 360,661,000USD | 416,464,000USD |
| Unclassified Non Current Liabilities | 5,487,000USD | 11,681,000USD | 78,126,000USD | — | -103,486,000USD | -110,795,000USD | -110,795,000USD | -110,971,000USD |
| Unclassified Equity | 1,625,831,000USD | 1,588,191,000USD | 1,540,322,000USD | 1,454,003,000USD | 1,181,164,000USD | 966,237,000USD | 952,015,000USD | 930,699,000USD |
| Net Receivables | — | 0USD | 5,159,000USD | 62,000USD | 13,000USD | 15,000USD | 68,000USD | 2,000USD |
| Unclassified Non Current Assets | — | 44,099,000USD | 33,893,000USD | -12,725,000USD | -3,351,000USD | -19,496,000USD | -3,789,000USD | -4,869,000USD |
| Inventory | — | — | -5,159,000USD | -62,000USD | -13,000USD | 1,352,000USD | -68,000USD | 1USD |
| Unclassified Current Liabilities | — | — | -67,405,000USD | — | — | -4,891,000USD | -4,579,000USD | -110,188,000USD |
| Other Liab | — | — | — | 85,846,000USD | 103,486,000USD | 110,795,000USD | 110,795,000USD | 110,971,000USD |
| Other Assets | — | — | — | 30,929,000USD | 10,422,000USD | 31,140,000USD | 13,745,000USD | 14,571,000USD |
| Accumulated Other Comprehensive Income | — | — | — | 0USD | 0USD | — | -8,007,000USD | -10,504,000USD |
| Non Current Liabilities Other | — | — | — | 553,000USD | 6,939,000USD | 12,879,000USD | 18,391,000USD | 50,454,000USD |
| Net Tangible Assets | — | — | — | 622,042,000USD | 466,042,000USD | 184,006,000USD | 272,921,000USD | 322,998,000USD |
| Deferred Long Term Liab | — | — | — | — | 102,933,000USD | 110,242,000USD | 110,242,000USD | 110,418,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 32,721,000USD | -21,589,000USD | -36,541,000USD | -125,767,000USD | -60,195,000USD | -57,956,000USD | -59,001,000USD | 66,886,000USD |
| Depreciation | 184,000USD | 218,000USD | 229,000USD | 225,000USD | 223,000USD | 221,000USD | -436,000USD | 231,000USD |
| Stock Based Compensation | 6,915,000USD | 7,074,000USD | 7,199,000USD | 12,418,000USD | 10,949,000USD | 10,520,000USD | 11,020,000USD | 12,041,000USD |
| Other Non Cash Items | -4,464,000USD | 825,000USD | 715,000USD | 683,000USD | 688,000USD | 692,000USD | -806,657USD | 662,000USD |
| Change In Working Capital | -6,479,000USD | -9,840,000USD | -12,167,000USD | 21,190,000USD | -3,356,000USD | 988,000USD | 5,579,000USD | -61,053,000USD |
| Total Cash From Operating Activities | 28,877,000USD | -23,312,000USD | -40,565,000USD | -46,340,000USD | -53,363,000USD | -47,772,000USD | -45,186,000USD | 15,959,000USD |
| Capital Expenditures | 0USD | -2,040USD | -10,000USD | -86,000USD | -42,000USD | -43,000USD | -9,000USD | -143,000USD |
| Free Cash Flow | 28,877,000USD | -23,312,000USD | -40,575,000USD | -46,426,000USD | -53,405,000USD | -47,815,000USD | -45,195,000USD | 15,816,000USD |
| Total Cash From Financing Activities | -6,946,000USD | 2,051USD | -17,000USD | -74,000USD | -48,000USD | -59,000USD | 333,000USD | 444,000USD |
| Sale Purchase Of Stock | -6,946,000USD | -170,000USD | -17,000USD | -74,000USD | -48,000USD | -58,000USD | -94,000USD | -147,000USD |
| Change In Cash | 21,931,000USD | -23,312,000USD | -40,592,000USD | -46,500,000USD | -53,453,000USD | -47,874,000USD | -44,862,000USD | 16,260,000USD |
| Begin Period Cash Flow | 308,391,000USD | 331,703,000USD | 372,295,000USD | 418,795,000USD | 472,248,000USD | 520,122,000USD | 564,984,000USD | 548,724,000USD |
| End Period Cash Flow | 330,322,000USD | 308,391,000USD | 331,703,000USD | 372,295,000USD | 418,795,000USD | 472,248,000USD | 520,122,000USD | 564,984,000USD |
| Other Cashflows From Financing Activities | -6,946,000USD | 145,405USD | -18,795USD | -78,609USD | -48,000USD | -1,000USD | 427,000USD | 591,000USD |
| Unclassified Financing Cash Flow | 6,946,000USD | — | — | — | — | — | — | — |
| Change To Account Receivables | — | 0USD | 0USD | 0USD | 0USD | 0USD | 20,620USD | -20,620USD |
| Total Cashflows From Investing Activities | — | 2,036USD | -10,000USD | -86,000USD | -42,000USD | -43,000USD | -9,000USD | -143,000USD |
| Investments | — | — | -10,000USD | -86,000USD | -42,000USD | -43,000USD | -9,000USD | -143,000USD |
| Unclassified Operating Cash Flow | — | — | — | 44,911,000USD | -1,672,000USD | -2,237,000USD | -1,541,343USD | -2,808,000USD |
| Issuance Of Capital Stock | — | — | — | — | — | 0USD | 0USD | 0USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | 984USD | -984USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -244,092,000USD | -122,310,000USD | -147,028,000USD | -116,949,000USD | 66,975,000USD | -111,144,000USD | -77,677,000USD | -155,645,000USD |
| Depreciation | 895,000USD | 893,000USD | 928,000USD | 744,000USD | 1,115,000USD | 1,514,000USD | 6,820,000USD | 3,216,000USD |
| Stock Based Compensation | 37,640,000USD | 45,964,000USD | 40,914,000USD | 31,322,000USD | 24,658,000USD | 22,014,000USD | 23,585,000USD | 27,010,000USD |
| Other Non Cash Items | 2,911,000USD | 2,692,000USD | 7,499,000USD | 5,998,000USD | 5,688,000USD | 5,463,000USD | 37,303,000USD | 4,280,000USD |
| Change To Account Receivables | 0USD | 5,159,000USD | -5,159,000USD | 79,000USD | 15,000USD | 53,000USD | 53,000USD | 238,000USD |
| Change In Working Capital | -4,173,000USD | -67,943,000USD | -20,530,000USD | -18,803,000USD | -10,404,000USD | 3,479,000USD | -4,449,000USD | 94,452,000USD |
| Total Cash From Operating Activities | -163,580,000USD | -150,050,000USD | -133,906,000USD | -108,821,000USD | 92,605,000USD | -80,362,000USD | -52,969,000USD | -28,276,000USD |
| Capital Expenditures | -138,000USD | -298,000USD | -2,810,000USD | -464,000USD | -575,000USD | -196,000USD | -555,000USD | -1,768,000USD |
| Free Cash Flow | -163,718,000USD | -150,348,000USD | -136,716,000USD | -109,285,000USD | 92,030,000USD | -80,558,000USD | -53,524,000USD | -30,044,000USD |
| Total Cashflows From Investing Activities | -138,000USD | -298,000USD | -2,773,000USD | -464,000USD | -575,000USD | -196,000USD | -547,000USD | -1,729,000USD |
| Total Cash From Financing Activities | -139,000USD | 1,554,000USD | 45,103,000USD | 241,457,000USD | 190,332,000USD | 215,000USD | 228,000USD | 40,044,000USD |
| Sale Purchase Of Stock | -139,000USD | -353,000USD | — | — | 93,593,000USD | 215,000USD | 228,000USD | 44,444,000USD |
| Issuance Of Capital Stock | 0USD | 0USD | 232,782,000USD | 223,616,000USD | 174,788,000USD | 78,367,000USD | — | 39,758,000USD |
| Change In Cash | -163,857,000USD | -148,794,000USD | -91,576,000USD | 132,172,000USD | 282,362,000USD | -80,343,000USD | -53,288,000USD | 10,039,000USD |
| Begin Period Cash Flow | 472,248,000USD | 621,042,000USD | 712,618,000USD | 580,446,000USD | 298,084,000USD | 378,427,000USD | 431,715,000USD | 421,676,000USD |
| End Period Cash Flow | 308,391,000USD | 472,248,000USD | 621,042,000USD | 712,618,000USD | 580,446,000USD | 298,084,000USD | 378,427,000USD | 431,715,000USD |
| Other Cashflows From Financing Activities | -139,000USD | 1,907,000USD | 21,520,000USD | 17,841,000USD | 15,544,000USD | 215,000USD | 228,000USD | 4,686,000USD |
| Unclassified Operating Cash Flow | 43,239,000USD | -9,346,000USD | -15,689,000USD | -11,133,000USD | 4,573,000USD | -1,688,000USD | -38,551,000USD | -1,589,000USD |
| Investments | — | -298,000USD | -1,412,000USD | -464,000USD | -575,000USD | -196,000USD | -547,000USD | -1,729,000USD |
| Change To Inventory | — | — | -8,896,000USD | — | -10,275,000USD | — | — | 9,600,000USD |
| Other Cashflows From Investing Activities | — | — | 37,000USD | — | — | — | 8,000USD | 39,000USD |
| Unclassified Investing Cash Flow | — | — | 1,412,000USD | — | — | — | — | 1,729,000USD |
| Unclassified Financing Cash Flow | — | — | -209,199,000USD | — | 81,195,000USD | — | — | -4,686,000USD |
| Change To Liabilities | — | — | — | -1,990,000USD | -144,000USD | 7,728,000USD | -539,000USD | 85,075,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | 282,362,000USD | -80,343,000USD | -53,288,000USD | 10,039,000USD |
| Net Borrowings | — | — | — | — | — | — | — | -4,400,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2025Quarterly · 2025-03-31 | Product | Collaboration | 2,778,000 | USD | 0001559053-26-000017 |
| Q1 2025Quarterly · 2025-03-31 | Product | License | 50,000 | USD | 0001559053-26-000017 |
| Q3 2024Quarterly · 2024-09-30 | Product | Collaboration | 970,000 | USD | 0001559053-25-000044 |
| Q3 2024Quarterly · 2024-09-30 | Product | License | 0 | USD | 0001559053-25-000044 |
| Q2 2024Quarterly · 2024-06-30 | Product | Collaboration | 132,014,000 | USD | 0001559053-25-000031 |
| Q2 2024Quarterly · 2024-06-30 | Product | License | 0 | USD | 0001559053-25-000031 |
| Q1 2024Quarterly · 2024-03-31 | Product | Collaboration | 0 | USD | 0001559053-25-000023 |
| Q1 2024Quarterly · 2024-03-31 | Product | License | 50,000 | USD | 0001559053-25-000023 |
| Q4 2023Quarterly · 2023-12-31 | Product | Collaboration | 316,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Product | License | 0 | USD | Legacy provider |
| FY 2023Yearly · 2023-12-31 | Product | Collaboration | 91,320,000 | USD | 0001559053-26-000008 |
| FY 2023Yearly · 2023-12-31 | Product | License | 50,000 | USD | 0001559053-26-000008 |
| Q3 2023Quarterly · 2023-09-30 | Product | Collaboration | 84,866,000 | USD | 0001559053-24-000032 |
| Q3 2023Quarterly · 2023-09-30 | Product | License | 0 | USD | 0001559053-24-000032 |
| Q2 2023Quarterly · 2023-06-30 | Product | Collaboration | 4,019,000 | USD | 0001559053-24-000025 |
| Q2 2023Quarterly · 2023-06-30 | Product | License | 0 | USD | 0001559053-24-000025 |
| Q1 2023Quarterly · 2023-03-31 | Product | Collaboration | 2,119,000 | USD | 0001559053-24-000014 |
| Q1 2023Quarterly · 2023-03-31 | Product | License | 50,000 | USD | 0001559053-24-000014 |
| FY 2020Yearly · 2020-12-31 | Product | Collaboration | 564,000 | USD | 0001559053-23-000005 |
| FY 2020Yearly · 2020-12-31 | Product | License | 289,000 | USD | 0001559053-23-000005 |
| FY 2019Yearly · 2019-12-31 | Product | Collaboration | 800,000 | USD | 0001559053-21-000008 |
| FY 2019Yearly · 2019-12-31 | Product | License | 0 | USD | 0001559053-21-000008 |
| FY 2019Yearly · 2019-12-31 | Product | Other | 14,000 | USD | 0001559053-21-000008 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.